US Deferasirox Market Trends in Iron Overload Treatment
The US deferasirox market is supported by the growing need for effective iron chelation therapy among patients experiencing transfusional iron overload. Increasing prevalence of conditions requiring regular blood transfusions, including certain anemias and blood disorders, is contributing to demand for oral iron chelation treatments. Growing awareness of iron overload management and the...
0 Kommentare 0 Geteilt 2 Ansichten 0 Bewertungen